These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 8863504

  • 1. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
    Navarro M, Rodriquez de Fonseca F, Alvarez E, Chowen JA, Zueco JA, Gomez R, Eng J, Blázquez E.
    J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.
    Seeley RJ, Blake K, Rushing PA, Benoit S, Eng J, Woods SC, D'Alessio D.
    J Neurosci; 2000 Feb 15; 20(4):1616-21. PubMed ID: 10662851
    [Abstract] [Full Text] [Related]

  • 4. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
    Larsen PJ, Tang-Christensen M, Jessop DS.
    Endocrinology; 1997 Oct 15; 138(10):4445-55. PubMed ID: 9322962
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats.
    Schick RR, Zimmermann JP, vorm Walde T, Schusdziarra V.
    Am J Physiol Regul Integr Comp Physiol; 2003 Jun 15; 284(6):R1427-35. PubMed ID: 12776726
    [Abstract] [Full Text] [Related]

  • 7. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL, Huang Q, Brown TJ, Drucker DJ.
    Gastroenterology; 2004 Aug 15; 127(2):546-58. PubMed ID: 15300587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.
    Meeran K, O'Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, Taylor GM, Sunter D, Steere J, Choi SJ, Ghatei MA, Bloom SR.
    Endocrinology; 1999 Jan 15; 140(1):244-50. PubMed ID: 9886831
    [Abstract] [Full Text] [Related]

  • 11. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
    Tang-Christensen M, Larsen PJ, Göke R, Fink-Jensen A, Jessop DS, Møller M, Sheikh SP.
    Am J Physiol; 1996 Oct 15; 271(4 Pt 2):R848-56. PubMed ID: 8897973
    [Abstract] [Full Text] [Related]

  • 12. A role for glucagon-like peptide-1 in the central regulation of feeding.
    Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR.
    Nature; 1996 Jan 04; 379(6560):69-72. PubMed ID: 8538742
    [Abstract] [Full Text] [Related]

  • 13. The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem.
    Alvarez E, Martínez MD, Roncero I, Chowen JA, García-Cuartero B, Gispert JD, Sanz C, Vázquez P, Maldonado A, de Cáceres J, Desco M, Pozo MA, Blázquez E.
    J Neurochem; 2005 Feb 04; 92(4):798-806. PubMed ID: 15686481
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem.
    Thiele TE, Seeley RJ, D'Alessio D, Eng J, Bernstein IL, Woods SC, van Dijk G.
    Brain Res; 1998 Aug 10; 801(1-2):164-70. PubMed ID: 9729361
    [Abstract] [Full Text] [Related]

  • 18. Coexpression of glucagon-like peptide-1 (GLP-1) receptor, vasopressin, and oxytocin mRNAs in neurons of the rat hypothalamic supraoptic and paraventricular nuclei: effect of GLP-1(7-36)amide on vasopressin and oxytocin release.
    Zueco JA, Esquifino AI, Chowen JA, Alvarez E, Castrillón PO, Blázquez E.
    J Neurochem; 1999 Jan 10; 72(1):10-6. PubMed ID: 9886049
    [Abstract] [Full Text] [Related]

  • 19. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats.
    Davis HR, Mullins DE, Pines JM, Hoos LM, France CF, Compton DS, Graziano MP, Sybertz EJ, Strader CD, Van Heek M.
    Obes Res; 1998 Mar 10; 6(2):147-56. PubMed ID: 9545022
    [Abstract] [Full Text] [Related]

  • 20. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro.
    Dalvi PS, Nazarians-Armavil A, Purser MJ, Belsham DD.
    Endocrinology; 2012 May 10; 153(5):2208-22. PubMed ID: 22334721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.